PharmaCyte Biotech Inc. (PMCB)
NASDAQ: PMCB
· Real-Time Price · USD
0.94
-0.07 (-6.79%)
At close: Aug 20, 2025, 3:19 PM
PharmaCyte Biotech Cash Flow Statement
Financials in USD. Fiscal
year is
May - April.
| Fiscal Year | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 |
Net Income | 30.66M | 20.25M | 22.68M | 26.94M | 333.76K | -1.14M | -1.28M | -5.95M | -4.32M | -5.61M | -5.66M | -4.76M | -4.24M | -3.78M | -3.72M | -3.69M | -3.55M | -3.34M | -3.46M | -3.58M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 478.64K | 414.69K | 1.02M | 897.37K | 674.69K | 36.62K | -8.14K | -11 | 7.33K | 651.07K | 36.79K | 50.1K | 77.96K | 92.93K | 164.45K | 266.39K | 370.83K | 479.35K | 576.85K | 656.61K |
Other Working Capital | 1.67M | 508.6K | 455.00 | -41.87K | -592.81K | -625.06K | -394.92K | -741.41K | -151.47K | -191.57K | 359.32K | 245.29K | -24.06K | -157.74K | -640.13K | -355.04K | -132.03K | -33.18K | 26.89K | 274.75K |
Other Non-Cash Items | -35.79M | -23.45M | -25.86M | -30.5M | -3.46M | -1.05M | -514.18K | 3.41M | 517.97K | -122.9K | -286.33K | 12.36K | 34.85K | -38.22K | -35.25K | -20.66K | -4.87K | 126.8K | 147.48K | 201.88K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 1.68M | 509.35K | 222.89K | -206.05K | 298.89K | 43.82K | -665.28K | -117.56K | -297.17K | 92.89K | 1.16M | 735.82K | 9.04K | -144.04K | -563.21K | -574.13K | -145.61K | -294.51K | -57.57K | 592.04K |
Operating Cash Flow | -2.98M | -2.27M | -1.94M | -2.87M | -2.15M | -2.11M | -2.47M | -2.37M | -3.79M | -4.7M | -4.45M | -3.96M | -4.12M | -3.87M | -4.16M | -4.02M | -3.33M | -3.03M | -2.79M | -2.13M |
Capital Expenditures | -5 | -5 | -4 | 5.00 | 8.00 | 8.00 | 4.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | 5M | n/a | -7M | n/a | -5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -5,000B | -5,000B | -5,000B | -5,000B | -643.25K | -643.25K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | -5,000B | -5,000B | -5,000B | -5,000B | -5.64M | -643.25K | n/a | n/a | n/a | -55.69M | -55.69M | -55.69M | -55.69M | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -50.8K | -50.8K | -50.8K | -50.8K | n/a | -38.17K | -75.91K | -113.25K | -113.25K | -75.08K | -37.34K |
Common Stock Repurchased | -25.03M | -35.55M | -38.65M | -28.07M | -44.36M | -37.97M | -34.71M | -37.93M | -13.56M | -9.25M | -5.48M | -2.09M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | -16.19M | -22,457.2B | -22,457.2B | -22,457.2B | -22,457.2B | -319.85K | -319.85K | -319.85K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 16.19M | 22,457.2B | 22,457.2B | 22,457.2B | 22,457.2B | -1.94M | -1.94M | -1.94M | 880.00 | -31.67M | -31.67M | 880.00 | n/a | 31.72M | 31.72M | 50.8K | 50.8K | 62.85K | 62.85K | 62.85K |
Financial Cash Flow | -25.03M | -35.55M | -38.65M | -27.16M | -10.71M | -4.32M | -1.06M | -5.19M | -13.56M | -9.3M | 50.17M | 140.91M | 143M | 143.11M | 87.37M | 2.82M | 4.64M | 5.98M | 6.47M | 3.96M |
Net Cash Flow | -35.01M | -44.83M | -52.59M | -42.03M | -17.86M | -11.43M | -3.54M | -7.57M | -17.36M | -14M | -9.98M | 81.27M | 83.2M | 83.55M | 83.22M | -1.21M | 1.31M | 2.95M | 3.67M | 1.84M |
Free Cash Flow | -2.98M | -2.27M | -1.94M | -2.87M | -2.15M | -2.11M | -2.47M | -2.37M | -3.79M | -4.7M | -4.45M | -3.96M | -4.12M | -3.87M | -4.16M | -4.02M | -3.33M | -3.03M | -2.79M | -2.13M |